9 recruiting. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Recruiting 9 |
Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock Hydrocortisone plus Fludrocortisone, Standard care - Septic Shock | Phase 4 | Recruiting | Northern Jiangsu People's Hospital | 336 | 2026-03-02 | 2026-03-04 |
| Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis Meropenem, Piperacillin/Tazobactam - Sepsis, Septic Shock | Phase 4 | Recruiting | Scandinavian Critical Care Trials Group | 5800 | 2025-06-26 | 2025-07-03 |
| Early Versus Late Adjunctive Vasopressin in Septic Shock vasopressin - early initiation, vasopressin - standard initiation - Sepsis, Septic Shock | Phase 4 | Recruiting | The Cleveland Clinic | 300 | 2025-04-29 | 2026-08-31 |
| Early Angiotensin II in the Emergency Department Angiotensin II Infusion - Septic Shock | Phase 4 | Recruiting | Brett A Faine | 20 | 2025-04-01 | 2026-09-02 |
| Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis Double dosing of beta-lactam antibiotic - Sepsis - to Reduce Mortality in the Intensive Care Unit, Sepsis | Phase 4 | Recruiting | Erasmus Medical Center | 980 | 2025-01-03 | 2025-01-09 |
| Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial Iron, EPO, 0.9 % NaCl - Anemia, Sepsis | Phase 4 | Recruiting | Piotr Czempik | 200 | 2024-11-10 | 2024-12-27 |
| The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients Dexmedetomidine, Propofol - Sepsis, Septic Shock | Phase 4 | Recruiting | Cairo University | 128 | 2024-10-01 | 2024-10-09 |
| The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis Shenfu Injection - Septic Cardiomyopathy, Septic Shock | Phase 4 | Recruiting | First Affiliated Hospital of Wannan Medical College | 440 | 2024-10-01 | 2025-03-27 |
| Albumin and Crystalloid Administration in Septic Shock Treatment, Placebo - Septic Shock | Phase 4 | Recruiting | Asan Medical Center | 2426 | 2022-01-17 | 2026-07-16 |
Shock, Septic (9) · Sepsis (5) · Acute Kidney Injury (1) · Anemia (1) · Critical Illness (1) · Diabetes Insipidus (1)
Infections (9) · Inflammation (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Shock (9) · Systemic Inflammatory Response Syndrome (9) · Sepsis (4) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Disease Attributes (1) · Endocrine System Diseases (1)
Albumins (1) · Crystalloid Solutions (1) · Dexmedetomidine (1) · Fludrocortisone (1) · Hydrocortisone (1) · Iron (1) · Meropenem (1) · Piperacillin, Tazobactam Drug Combination (1) · Propofol (1) · Shen-Fu (1) · Sodium Chloride (1) · Standard of Care (1) · Therapeutics (1) · Vasopressins (1) · fludrocortisone acetate (1)
Asan Medical Center (1) · Brett A Faine (1) · Cairo University (1) · Erasmus Medical Center (1) · First Affiliated Hospital of Wannan Medical College (1) · Northern Jiangsu People's Hospital (1) · Piotr Czempik (1) · Scandinavian Critical Care Trials Group (1) · The Cleveland Clinic (1)
China (2) · United States (2) · Denmark (1) · Egypt (1) · Netherlands (1) · Poland (1) · South Korea (1)
Amany M Mohamed, Ph.D (1) · Gretchen L. Sacha, PharmD (1) · Kanzy M Hassan, B. Pharm (1) · Nirmeen A Sabry, Ph.D (1) · Qingquan Lyu, Master (1) · Ramadan M Khalil, MD (1)
PMID 34582425, PMID 40119275, PMID 42674465
2023 (1)